|
Dr. Marshak is Senior Vice President Research and Development and Chief Technology Officer for Cambrex and a renowned molecular biologist who has served on several NIH Study Sections the Medical and Scientific Advisory Board of the Dystonia Medical Research Foundation and the Editorial Board of the Journal of Biological Chemistry. He is also an Adjunct Associate Professor of Oncology and of Molecular Biology & Genetics at the Johns Hopkins University School of Medicine. Prior to joining Cambrex in 2000 Dr. Marshak held various Research and Development positions with Osiris Therapeutics and was a former senior staff investigator at the Cold Spring Harbor Laboratory (1986-1994). Daniel Marshak received his B.A. from Harvard University in biochemistry and molecular biology and his Ph.D. from Rockefeller University. He did postdoctoral research in pharmacology at Vanderbilt University School of Medicine and at the National Institutes of Health.
| 